Non-invasive markers of fibrosis at 3 years of follow-up in liver transplant recipients with moderate/severe hepatitis C recurrence, successfully treated with DAAs
2019 ◽
Vol 70
(1)
◽
pp. e138-e139
◽
2018 ◽
Vol 50
(5)
◽
pp. 1437-1443
◽
1996 ◽
Vol 9
(s1)
◽
pp. S204-S209
◽
2002 ◽
Vol 34
(5)
◽
pp. 1561-1562
◽
2007 ◽
Vol 21
(4)
◽
pp. 526-531
◽
Keyword(s):